PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
申请人:Arora Nidhi
公开号:US20120015962A1
公开(公告)日:2012-01-19
Compounds of the formula I or II:
wherein X, m, Ar, R
1
and R
2
are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
Synthesis of heterocyclic compounds. Part XXII. Routes to naphthimidazoles and imidazoquinolines
作者:H. Suschitzky、M. E. Sutton
DOI:10.1039/j39680003058
日期:——
Various N-o-azidonaphthyl and -azidoquinolylheterocycles decomposed thermally in nitrobenzene and in some cases photolytically in benzene to give the title compounds. Similar cyclisations were effected by the action of triethyl phosphite on the corresponding nitro-compounds. Finally, oxidative ring-closure of some o-acylamidoanalogues of the above naphthalenes and quinolines with performic acid is
Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
申请人:Hoffmann-La Roche Inc.
公开号:US09255110B2
公开(公告)日:2016-02-09
Compounds of the formula I or II:
wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
PYRAZOLO[1,5A]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
申请人:F. Hoffmann-La Roche AG
公开号:EP3252054A1
公开(公告)日:2017-12-06
Compounds of the formula I or II:
wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
式 I 或 II 的化合物:
其中 X、m、Ar、R1 和 R2 如本文所定义。上述化合物可用于治疗 IRAK 介导的病症。
Fourneau; Trefouel; Trefouel, Bulletin de la Societe Chimique de France, 1930, vol. <4> 47, p. 749